Protective actions of PJ34, a poly(ADP-ribose)polymerase inhibitor, on the blood-brain barrier after traumatic brain injury in mice.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Neuroscience

• Publication date

  2015-04-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.neuroscience.2015.01.070PMID 25668593
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Essential Role of Program Death 1-Ligand 1 in Regulatory T-Cell–Afforded Protection Against Blood–Brain Barrier Damage After Stroke

  2014cited by this paper
• PARP-1 Inhibition Attenuates Neuronal Loss, Microglia Activation and Neurological Deficits after Traumatic Brain Injury

  2014cited by this paper
• Prostaglandin F2α FP receptor antagonist improves outcomes after experimental traumatic brain injury

  2013cited by this paper
• IκBα deficiency in brain leads to elevated basal neuroinflammation and attenuated response following traumatic brain injury: implications for functional recovery

  2012cited by this paper
• Correction: Wogonin Improves Histological and Functional Outcomes, and Reduces Activation of TLR4/NF-κB Signaling after Experimental Traumatic Brain Injury

  2012cited by this paper
• Blood–brain barrier permeability is positively correlated with cerebral microvascular perfusion in the early fluid percussion-injured brain of the rat

  2012cited by this paper
• Wogonin Improves Histological and Functional Outcomes, and Reduces Activation of TLR4/NF-κB Signaling after Experimental Traumatic Brain Injury

  2012cited by this paper
• The role of hypoxia-inducible factor-1α, aquaporin-4, and matrix metalloproteinase-9 in blood-brain barrier disruption and brain edema after traumatic brain injury.

  2011cited by this paper
• A mouse model of blast-induced mild traumatic brain injury.

  2011cited by this paper
• microspora triprenyl phenol-7 , a novel fibrinolytic agent , suppresses uperoxide production , matrix metalloproteinase-9 expression , and thereby ttenuates ischemia / reperfusion injury in rat brain

  2011cited by this paper
• Blood–Brain Barrier Pathophysiology in Traumatic Brain Injury

  2011cited by this paper
• Matrix Metalloproteinase-9 in an Exploratory Trial of Intravenous Minocycline for Acute Ischemic Stroke

  2011cited by this paper
• Surveillance for traumatic brain injury-related deaths--United States, 1997-2007.

  2011influential reference
• Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies.

  2010cited by this paper
• Trauma mortality in mature trauma systems: are we doing better? An analysis of trauma mortality patterns, 1997-2008.

  2010cited by this paper
• Effect of Acute Poly(ADP-Ribose) Polymerase Inhibition by 3-AB on Blood–Brain Barrier Permeability and Edema Formation after Focal Traumatic Brain Injury in Rats

  2010influential reference
• Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NF-kappaB pathway.

  2009cited by this paper
• Cysteinyl-leukotriene receptor antagonist montelukast decreases blood–brain barrier permeability but does not prevent oedema formation in traumatic brain injury

  2009cited by this paper
• Role of Interleukin-1&bgr; in Early Brain Injury After Subarachnoid Hemorrhage in Mice

  2009cited by this paper
• Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage.

  2008cited by this paper
• Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice.

  2008cited by this paper
• Neuroprotective Mechanism of Taurine due to Up-regulating Calpastatin and Down-regulating Calpain and Caspase-3 during Focal Cerebral Ischemia

  2008cited by this paper
• Dynamic Changes in the Recovery after Traumatic Brain Injury in Mice: Effect of Injury Severity on T2-Weighted MRI Abnormalities, and Motor and Cognitive Functions

  2008cited by this paper
• Contribution of Poly(ADP-Ribose) Polymerase to Postischemic Blood—Brain Barrier Damage in Rats

  2007cited by this paper
• Electromagnetic Controlled Cortical Impact Device for Precise, Graded Experimental Traumatic Brain Injury

  2007cited by this paper
• Anti-apoptotic effect of granulocyte-colony stimulating factor after focal cerebral ischemia in the rat.

  2006cited by this paper
• Anti‐inflammatory effects of PJ34, a poly(ADP‐ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice

  2006cited by this paper
• Role of Poly(ADP-Ribose) Polymerase-1 Activation in the Pathogenesis of Diabetic Complications: Endothelial Dysfunction, as a Common Underlying Theme

  2005cited by this paper
• Poly(ADP-Ribose) Polymerase-1 Promotes Microglial Activation, Proliferation, and Matrix Metalloproteinase-9-Mediated Neuron Death1

  2005cited by this paper
• Effect of 3-aminobenzamide, PARP inhibitor, on matrix metalloproteinase-9 level in plasma and brain of ischemic stroke model.

  2005cited by this paper
• Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia.

  2005cited by this paper
• BLOOD-BRAIN BARRIER CHANGES DURING COMPENSATED AND DECOMPENSATED HEMORRHAGIC SHOCK

  2005cited by this paper
• Closed head injury--an inflammatory disease?

  2005cited by this paper
• Tumor necrosis factor-alpha neutralization reduced cerebral edema through inhibition of matrix metalloproteinase production after transient focal cerebral ischemia.

  2005influential reference
• The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals

  2004cited by this paper
• Interaction Between Inducible Nitric Oxide Synthase and Poly(ADP-ribose) Polymerase in Focal Ischemic Brain Injury

  2004cited by this paper
• Poly(ADP-ribose) polymerase inhibition protect neurons and the white matter and regulates the translocation of apoptosis-inducing factor in stroke.

  2004cited by this paper
• Acute alterations in microvascular basal lamina after subarachnoid hemorrhage.

  2004cited by this paper
• A dual role for poly‐ADP‐ribosylation in spatial memory acquisition after traumatic brain injury in mice involving NAD+ depletion and ribosylation of 14‐3‐3γ

  2003cited by this paper
• Poly(ADP‐ribose) polymerase‐1 activity promotes NF‐κB‐driven transcription and microglial activation: implication for neurodegenerative disorders

  2003cited by this paper
• Changes in cytoskeletal and tight junctional proteins correlate with decreased permeability induced by dexamethasone in cultured rat brain endothelial cells.

  2003cited by this paper
• Meningitis-Associated Central Nervous System Complications are Mediated by the Activation of Poly(ADP-ribose) Polymerase

  2002influential reference
• The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-κB in inflammatory disorders

  2002cited by this paper
• Matrix Metalloproteinases and Neuroinflammation in Multiple Sclerosis

  2002cited by this paper
• The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors

  2002cited by this paper
• Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia

  2002cited by this paper
• The Sequence-specific DNA Binding of NF-κB Is Reversibly Regulated by the Automodification Reaction of Poly (ADP-ribose) Polymerase 1*

  2001cited by this paper
• Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats.

  2001cited by this paper
• Effects of Matrix Metalloproteinase-9 Gene Knock-Out on the Proteolysis of Blood–Brain Barrier and White Matter Components after Cerebral Ischemia

  2001cited by this paper
• Experimental Closed Head Injury: Analysis of Neurological Outcome, Blood–Brain Barrier Dysfunction, Intracranial Neutrophil Infiltration, and Neuronal Cell Death in Mice Deficient in Genes for Pro-Inflammatory Cytokines

  2000cited by this paper
• Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia

  1997cited by this paper
• Effect of Brain Edema on Infarct Volume in a Focal Cerebral Ischemia Model in Rats

  1993cited by this paper
• Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

  1992cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Laminins and the Blood-Brain Barrier.

  2025cites this paper
• LAMC1 attenuates neuronal apoptosis via FAK/PI3K/AKT signaling pathway after subarachnoid hemorrhage.

  2024cites this paper
• From spreading depolarization to blood–brain barrier dysfunction: navigating traumatic brain injury for novel diagnosis and therapy

  2024cites this paper
• Possible mechanisms involved in the neuroprotective effects of chrysin against mild traumatic brain injury-induced spatial cognitive decline: An in vivo study in a rat model.

  2023cites this paper
• Dual-targeting AAV9P1-mediated neuronal reprogramming in a mouse model of traumatic brain injury

  2023cites this paper
• Synthesis of Veliparib Prodrugs and Determination of Drug-Release-Dependent PARP-1 Inhibition

  2023cites this paper
• Megf10‐related engulfment of excitatory postsynapses by astrocytes following severe brain injury

  2023cites this paper
• Possible Action of Olaparib for Preventing Invasion of Oral Squamous Cell Carcinoma In Vitro and In Vivo

  2022cites this paper
• Radiation-induced neuroinflammation: a potential protective role for poly(ADP-ribose) polymerase inhibitors?

  2022cites this paper
• Laminin as a Biomarker of Blood–Brain Barrier Disruption under Neuroinflammation: A Systematic Review

  2022influential citation
• PARP1-mediated PARylation activity is essential for oligodendroglial differentiation and CNS myelination

  2021cites this paper
• Therapeutic Potentials of Poly (ADP‐Ribose) Polymerase 1 (PARP1) Inhibition in Multiple Sclerosis and Animal Models: Concept Revisiting

  2021cites this paper
• Impact of Different Pharmacological Treatments on Outcomes in Adult Rats after Traumatic Brain Injury: A Systematic Review and Meta-analysis

  2021cites this paper
• Targeted delivery of PARP inhibitors to neuronal mitochondria via biomimetic engineered nanosystems in a mouse model of traumatic brain injury.

  2021cites this paper
• The Dose-dependent Dual Effects of Corticosterone on Spatial Memory Ability After Traumatic Brain Injury Are Mediated by Two Corticosteroid Receptor Systems

  2021cites this paper
• The Dual Dose-Dependent Effects of Corticosterone on Hippocampal Cell Apoptosis After Traumatic Brain Injury Depend on the Activation Ratio of Mineralocorticoid Receptors to Glucocorticoid Receptors

  2021cites this paper
• Pharmacological inhibition of poly (ADP-ribose) polymerase by olaparib, prevents acute lung injury associated cognitive deficits potentially through suppression of inflammatory response.

  2020cites this paper
• NDT_A_281530 2975..2987

  2020influential citation
• Antiapoptotic and Anti-Inflammatory Effects of CPCGI in Rats with Traumatic Brain Injury

  2020cites this paper
• Inadequate Expression and Activation of Mineralocorticoid Receptor Aggravates Spatial Memory Impairment after Traumatic Brain Injury.

  2019cites this paper
• Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.

  2018cites this paper
• Flurbiprofen axetil attenuates cerebral ischemia/reperfusion injury by reducing inflammation in a rat model of transient global cerebral ischemia/reperfusion

  2018cites this paper
• PARP Inhibition Prevents Ethanol-Induced Neuroinflammatory Signaling and Neurodegeneration in Rat Adult-Age Brain Slice Cultures

  2018cites this paper
• Apolipoprotein E4 impairs spontaneous blood brain barrier repair following traumatic brain injury

  2018cites this paper
• Extracellular matrix and traumatic brain injury

  2018cites this paper
• Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases

  2018cites this paper
• Evaluation of neuroprotective effects of insulin on immuno-inflammatory and systemic disorders induced by kaliotoxin, a Kv1.3 channel blocker

  2018cites this paper
• Degradomics in Neurotrauma: Profiling Traumatic Brain Injury.

  2017cites this paper
• Protective Functions of PJ34, a Poly(ADP-ribose) Polymerase Inhibitor, Are Related to Down-Regulation of Calpain and Nuclear Factor-κB in a Mouse Model of Traumatic Brain Injury.

  2017cites this paper
• Alterations in nitric oxide homeostasis during traumatic brain injury.

  2017cites this paper
• Protective Effects of Calpain Inhibition on Neurovascular Unit Injury through Downregulating Nuclear Factor-κB-related Inflammation during Traumatic Brain Injury in Mice

  2017cites this paper
• Early to Long-Term Alterations of CNS Barriers After Traumatic Brain Injury: Considerations for Drug Development

  2017cites this paper
• Effects of Poly(ADP-Ribose) Polymerase-1 Inhibition in a Neonatal Rodent Model of Hypoxic-Ischemic Injury

  2017cites this paper
• The extracellular matrix protein laminin-10 promotes blood–brain barrier repair after hypoxia and inflammation in vitro

  2016cites this paper
• Protective effects of PARP inhibitor, PJ34, is related to down-regulation of calpain and NF-κB in a mouse model of TBI.

  2016cites this paper
• Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress

  2016cites this paper
• Concepts and Molecular Aspects in the Polypharmacology of PARP‐1 Inhibitors

  2016cites this paper
• PARP inhibition attenuates early brain injury through NF-κB/MMP-9 pathway in a rat model of subarachnoid hemorrhage.

  2016cites this paper
• Matrix Metalloproteinase-2 (MMP-2) Gene Deletion Enhances MMP-9 Activity, Impairs PARP-1 Degradation, and Exacerbates Hepatic Ischemia and Reperfusion Injury in Mice

  2015cites this paper